4.3 Article

Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole

Journal

PARASITOLOGY RESEARCH
Volume 117, Issue 3, Pages 705-712

Publisher

SPRINGER
DOI: 10.1007/s00436-017-5740-3

Keywords

Albendazole; Inclusion complex; Cyclodextrin; Solubility; Anthelmintic; Sheep

Categories

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/15704-3]
  2. Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior

Ask authors/readers for more resources

Albendazole (ABZ), a benzimidazole widely used to control gastrointestinal parasites, is poorly soluble in water, resulting in variable and incomplete bioavailability. This has favored the appearance ABZ-resistant nematodes and, consequently, an increase in its clinical ineffectiveness. Among the pharmaceutical techniques developed to increase drug efficacy, cyclodextrins (CDs) and other polymers have been extensively used with water-insoluble pharmaceutical drugs to increase their solubility and availability. Our objective was to prepare ABZ formulations, including beta-cyclodextrin (beta CD) or hydroxypropyl-beta-cyclodextrin (HP beta CD), associated or not to the water-soluble polymer polyvinylpyrrolidone (PVP). These formulations had their solubility and anthelmintic effect both evaluated in vitro. Also, their anthelmintic efficacy was evaluated in lambs naturally infected with gastrointestinal nematodes (GIN) through the fecal egg count (FEC) reduction test. In vitro, the complex ABZ/HP beta CD had higher solubility than ABZ/beta CD. The addition of PVP to the complexes increased solubility and dissolution rates more effectively for ABZ/HP beta CD than for ABZ/beta CD. In vivo, 48 lambs naturally infected with GIN were divided into six experimental groups: control, ABZ, ABZ/beta CD, ABZ/beta CD-PVP, ABZ/HP beta CD, and ABZ/HP beta CD-PVP. Each treated animal received 10 mg/kg of body weight (based on the ABZ dose) for three consecutive days. After 10 days of the last administered dose, treatment efficacy was calculated. The efficacy values were as follows: ABZ (70.33%), ABZ/beta CD (85.33%), ABZ/beta CD-PVP (82.86%), ABZ/HP beta CD (78.37%), and ABZ/HP beta CD-PVP (43.79%). In vitro, ABZ/HP beta CD and ABZ/HP beta CD-PVP had high solubility and dissolution rates. In vivo, although the efficacies of ABZ/beta CD, ABZ/beta CD-PVP, and ABZ/HP beta CD increased slightly when compared to pure ABZ, this increase was not significant (P > 0.05).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available